Diagnostic performance of ELISA, IFAT and Western blot for the detection of anti- antibodies in cats using a Bayesian analysis without a gold standard by unknown
RESEARCH Open Access
Diagnostic performance of ELISA,
IFAT and Western blot for the detection of
anti-Leishmania infantum antibodies in cats
using a Bayesian analysis without a gold
standard
Maria Flaminia Persichetti1, Laia Solano-Gallego2, Angela Vullo1, Marisa Masucci3, Pierre Marty4, Pascal Delaunay5,
Fabrizio Vitale6 and Maria Grazia Pennisi3*
Abstract
Background: Anti-Leishmania antibodies are increasingly investigated in cats for epidemiological studies or for the
diagnosis of clinical feline leishmaniosis. The immunofluorescent antibody test (IFAT), the enzyme-linked immunosorbent
assay (ELISA) and western blot (WB) are the serological tests more frequently used. The aim of the present study was to
assess diagnostic performance of IFAT, ELISA and WB to detect anti-L. infantum antibodies in feline serum samples
obtained from endemic (n = 76) and non-endemic (n = 64) areas and from cats affected by feline leishmaniosis (n = 21)
by a Bayesian approach without a gold standard.
Methods: Cut-offs were set at 80 titre for IFAT and 40 ELISA units for ELISA. WB was considered positive in presence of
at least a 18 KDa band. Statistical analysis was performed through a written routine with MATLAB software in
the Bayesian framework. The latent data and observations from the joint posterior were simulated in the Bayesian
approach by an iterative Markov Chain Monte Carlo technique using the Gibbs sampler for estimating sensitivity and
specificity of the three tests.
Results: The median seroprevalence in the sample used for evaluating the performance of tests was estimated at 0.27
[credible interval (CI) = 0.20–0.34]. The median sensitivity of the three different methods was 0.97 (CI: 0.86–1.00), 0.75 (CI:
0.61–0.87) and 0.70 (CI: 0.56–0.83) for WB, IFAT and ELISA, respectively. Median specificity reached 0.99 (CI: 0.96–1.00) with
WB, 0.97 (CI: 0.93–0.99) with IFAT and 0.98 (CI: 0.94–1.00) with ELISA. IFAT was more sensitive than ELISA (75 vs 70%) for
the detection of subclinical infection while ELISA was better for diagnosing clinical leishmaniosis when compared with
IFAT (98 vs 97%).
Conclusions: The overall performance of all serological techniques was good and the most accurate test for
anti-Leishmania antibody detection in feline serum samples was WB.
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Background
Leishmaniosis due to Leishmania infantum is a zoonotic
vector-borne disease of worldwide importance, transmit-
ted by phlebotominae sand flies. Dogs are the primary
reservoir host; however other animal species can be in-
fected, including cats [1, 2]. The role of cats as reservoirs
of L. infantum is strongly suspected as infected cats are
able to transmit the parasite to vector sand flies [3].
Moreover, clinical cases of feline leishmaniosis and sub-
clinical infections due to L. infantum are increasingly be-
ing reported in Europe [1, 2].
IFAT and ELISA are amongst the most common sero-
logical techniques used for the diagnosis and for clinical
and research studies on canine and feline L. infantum
infection [1, 4–6]. For both IFAT and ELISA, quantifica-
tion using antibody titer or optical density allows classi-
fication of antibody levels against L. infantum antigens.
IFAT method is considered the reference technique by
the World Organization for Animal Health (OIE) [7].
However, this technique depends on the operator’s skills
and experience for the microscopical reading of IFAT
antigen slides [4, 8]. Moreover, appropriate setting of
cut-off level is crucial in determining sensitivity (Se) and
specificity (Sp) of this test. Conversely, reading of ELISA
plates is rapidly operated in a plate reader at the re-
quired absorbance and, in addition to the selected cut-
off, Sp and Se strongly depend on the kind of antigen
used [9, 10]. Western blot (WB) analysis, mainly a quali-
tative serological method, distinguishes the molecular
weight of the L. infantum antigens stimulating antibody
production, but is less frequently used in veterinary
practice for the diagnosis of leishmaniosis [11]. One po-
tential field of application of WB method is the discrim-
ination between subclinical infections and disease [12].
Numerous epidemiological studies demonstrated the
presence of anti-Leishmania antibodies in feline sera by
means of different techniques such as IFAT, ELISA or
WB as previously reviewed elsewhere [1, 2]. It is import-
ant to highlight that sensitivity and specificity estimates
of these serological methods in cats unfortunately were
rarely evaluated [4, 11]. However, ELISA and WB tests
were reported to be more sensitive than IFAT [10, 13–15].
Variation in sensitivity and specificity is mainly attribut-
able to differences among the reference population stud-
ied and sampling strategies that are used for the validation
procedure [16]. In addition, the serological diagnostic
techniques used may have considerable influence on the
estimate obtained for the true seroprevalence; however,
comparative studies on serological techniques used in cats
are limited and scarce [4, 11, 17].
True differences of test accuracy among studies are
not directly observable because studies are not free of
random and systematic errors such as technical variation
of test characteristics (among laboratories; by time),
laboratory proficiency, choice of gold standard or cut-off
value for interpretation, and handling of intermediate or
uninterpretable results [16].
A common practice in many diagnostic accuracy stud-
ies is to evaluate a novel test by using another test as a
gold standard. This approach yields strongly biased test
accuracy estimates if the test considered gold standard
have Se and Sp not approaching 100%. This may occur
with leishmaniosis caused by L. infantum as a gold
standard technique does not exist for diagnosis of in-
fection or disease [18]. In order to avoid imperfect
standard bias, we used the Bayesian method which
has been proposed to estimate accuracy parameters of
the tests [19, 20] by an iterative Markov Chain Monte
Carlo (MCMC) technique using the Gibbs sampler
for estimating Se and Sp.
The aim of the present study was to assess diagnostic
performance of IFAT, ELISA and WB to detect anti-L.
infantum antibodies in feline serum samples obtained
from endemic (n = 76) and non-endemic (n = 64) areas
and from cats affected by feline leishmaniosis (n = 21) by
a Bayesian approach without a gold standard.
Methods
Feline serum samples
Overall, 161 residual feline sera samples were obtained
in 2013 as described below and stored at−20 °C until
analyzed.
Feline sera from a non-endemic area of leishmaniosis
Sixty-four feline serum samples of cats seen for medical
reasons at Beamount and Queen Mother Hospitals from
Royal Veterinary College University of London (UK),
where leishmaniosis is not endemic, were obtained. No
travel history, clinical or clinicopathological information
was available for these cats.
Feline sera of cats living in an endemic area of leishmaniosis
Seventy-six sera were from adult cats living in the South
of Italy and exposed to at least one sand fly transmission
season. They were collected at three veterinary clinics
from cats admitted for elective surgery (n = 35) or an-
nual health check (n = 4) and from 37 sick cats. One or
more of the following clinical conditions were detected
in these sick cats: anemia (n = 23), otitis (n = 11), skin
disease (n = 10), lower urinary tract disease (n = 9), sto-
matitis (n = 7), ocular disease (n = 5), fever (n = 3), re-
spiratory disease (n = 3). Two veterinary clinics were
located in the province of Messina (Ospedale Didattico
Veterinario, Università degli Studi di Messina, Messina
and Ambulatorio Veterinario S. Lucia, Lipari) and one in
Reggio Calabria (Clinica Veterinaria Camagna).
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Feline sera of cats affected by feline leishmaniosis
Twenty-one sera were of cats from South of Italy with clin-
ical and clinicopathological findings compatible with feline
leishmaniosis and diagnosis confirmed by at least two dif-
ferent parasitological methods among cytology, immuno-
histochemical staining, PCR, culture and xenodiagnosis [1].
Clinical findings included lymph node enlargement, skin
and mucosal lesions (nodules, ulcers, crusts), weight loss,
chronic stomatitis, ocular lesions; clinicopathological abnor-
malities found were normocytic normochromic anemia,
leukopenia, thrombocytopenia, pancytopenia, hyperprotei-
nemia, hypoalbuminemia, hypergammaglobulinemia, azote-
mia and increased urinary protein/creatinine ratio.
Serological techniques
IFAT
Immunoglobulin G antibodies were detected using L.
infantum (strain MHOM/IT/80/IPT1) antigen slides
produced by C.Re.Na.L. (Centro di Referenza Nazionale
per la Leishmaniosi, Palermo, Italy). Fluoresceinated goat
anti-cat immunoglobulin G (IgG) antibody (Anti-cat
IgG-FITC conjugate, SIGMA, Saint Louis, Missouri,
USA) diluted in PBS (from 1:180 to 1:200 according to
the batch) was used. The IFAT was performed according
to the manufacturer’s instructions and the end-point
titer of positive samples was determined preparing serial
two-fold dilutions of serum starting from 1:20. The cut-
off value for positivity was established at 1:80 [5].
ELISA
An ELISA previously described was performed with
slight modifications [11]. Briefly, each plate was coated
with 100 μl/well of 20 μg/ml antigen extracted from son-
icated L. infantum promastigote culture in 0.1 M car-
bonate/bicarbonate buffer (pH 9.6 at 25 °C) and
incubated overnight at 4 °C. Plates were then frozen and
stored at -20 °C.
One hundred microliters of cat sera, diluted 1:800 in
PBS-0.05% Tween 20 (PBST)-1% dried skimmed milk
(PBST-M), were added to each well and the plate was in-
cubated for 1 h at 37 °C in moist chamber. After three
washes with PBST for 3 min and one wash with PBS for
1 min, 100 μl per well of anti-cat IgG (Serotec, Bangkok,
Thailand) 1:10000 in PBST-M were added and incubated
for 1 h at 37 °C in moist chamber. The substrate solu-
tion (orthophenylenediamine, 0.5 mg/ml; Thermo Fisher,
Waltham, Massachusetts, USA) plus H2O2 (0.4 μl/ml) in
0.1 M phosphate/citrate buffer at pH 5.0, was added at
100 μl per well and developed for 20 ± 5 min at 24 °C in
the dark. The reaction was stopped with 100 μl of 2.5 M
H2SO4. The optical density (OD) was measured using an
automatic micro-ELISA (Anthos 2020, Cambridge, UK)
at a wavelength of 492 nm.
All plates included pooled serum from three sick cats
with a confirmed infection as a positive control (calibra-
tor) and serum of a cat from an area where leishmanio-
sis was not endemic as a negative control and all
samples were analyzed in duplicate. The reaction was
quantified as ELISA units (EU) related to positive cat
sera used as calibrators and arbitrarily set at 100 EU.
The cut-off was established at 40 ELISA units [mean ± 4
standard deviations (SD), of sera from 87 cats from non-
endemic area] [11].
Western blot
WB analysis was performed as described previously for
the diagnosis of clinical leishmaniosis due to L. infantum
and cutaneous leishmaniosis due to Leishmania major in
humans [21–23]. A nitrocellulose sheet sensitized with
2 mg/ml of antigen extract from L. infantum promasti-
gote culture (zymodeme, MON-1) was carried out as
described [21]. The homemade nitrocellulose paper was
rehydrated with 500 μl of non-fat dried milk and incu-
bated for 30 min in slow agitation. The liquid of each
gutter was removed and more 500 μl of milk were added
with 40 μl of feline serum samples and only 10 μl of
serum for the positive control. The bowl was left in slow
agitation overnight with a lid.
After 3 washes of 5 min with solution buffer (1/10 di-
lution of buffer + surfactant + NaN3), 1.2 ml of conjugate
anti-human [buffer + polyclonal rabbit anti-human IgG
conjugated with alkaline phosphatase + NaN3 (below
0.1%) + stabilizers, LDBIO] was distributed on each gut-
ter, the bowl was covered with a lid and incubated 1 h
30 min in slow agitation. After repeating the washes,
1.2 ml of substrate (buffer + NBT+ BCIP+ stabilizers,
LDBIO) was put in each gutter and incubated with a lid
in slow agitation for 20–30 min. The reaction was
stopped with distilled water when the characteristic bars
appeared on the positive control sample.
In WB analysis for the diagnosis of feline leishmaniosis
only bands with low molecular weight (14, 18, 21, 23
and 31 kDa) were considered diagnostic [11, 24]. In par-
ticular, only the presence of the 18 kDa band was sug-
gestive of L. infantum infection as described previously
in cats [17, 25] and humans [22, 23].
Statistical analysis
On each sample unit composed by a single feline serum
sample tested by IFAT, ELISA and WB, statistical ana-
lysis was performed through a written routine [20] with
MATLAB software using the Bayesian approach. The
Bayesian approach considers uncertainties associated
with all unknown quantities whether they are observed
or unobserved. Inference is drawn by constructing the
joint probability distribution of all unobserved quantities
based on all that is known about them. Let D denote the
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infection status of the cat and let Yi, i = 1, 2, 3, be di-
chotomous test variables assuming yi = {0, 1} respect-
ively, for negative and positive results. The Se and Sp of
the i-th test are Sei = P(yi = 1|D = 1) and Spi = P(yi = 0|D
= 0), respectively. We assume that the test outcomes for
a given cat are independent, conditional on infection sta-
tus of the cat. With three tests, for each one of the 23
possible realizations is computed the joint probability:
P y1; y2; y3ð Þ ¼ π
Y3
i¼1





with Pse yið Þ ¼
1−Sei if yi ¼ 0
Sei if yi ¼ 1

and Psp yið Þ ¼
Spi if yi ¼ 0
1−Spi if yi ¼ 1

The observed number of test results in each of the
eight cells in the 2 × 2 × 2 contingency table can be
thought as the sum of those that are truly infected and
those that are truly non-infected. Let us indicate as
d111|y111 the unknown frequency of truly infected cats
given the test response pattern (y1 = 1, y2 = 1, y3 = 1). It is
binomially distributed (y111, p111) where p111 is the posi-
tive predictive value of test pattern y111. Using Bayes’
theorem:

















and d111 is the expectation of d111|y111. The other prob-
abilities are similarly computed.
The latent data and observations from the joint poster-
ior are simulated in the Bayesian approach by an itera-
tive MCMC technique using the Gibbs sampler.
The Gibbs sampling proceeds iteratively with two
steps as follows: (i) arbitrary starting values for the pa-
rameters (one prevalence, three sensitivities and three
specificities) are chosen; and (ii) parameter values are
substituted within binomial distributions and di1i2i3 are
sampled from the respective binomial distributions.
For each one of the seven parameters, the augmented
beta posterior is computed. For example, for the first
test, Se1 it is beta αse1 þ d1…; βse1 þ d0…
 
where αSe1 and
βSe1 are the parameters of the beta prior of the Se and
for Sp1 it is beta αsp1 þ y0…−d0…; βse1 þ y1…−d1…
 
. The
joint posterior distribution of the parameters is obtained
as the product of these seven independent beta poste-
riors. Once the posterior distributions of all parameters
approach equilibrium condition the following qth quan-
tiles as parameters for the diagnostic test are considered:
q = 0.50 for calculating the median and q = 0.025 and
0.975 for calculating the 95% credibility intervals of the
sample generated from the posterior distribution. The
non-informative beta prior distribution for parameters
(i.e. α = 1 β = 1) of diagnostic test and prevalence sample
is employed.
In this study, we used J cycles of the Gibbs sampler
and the last N generations of the chain forms the sample
of the equilibrium distribution [20]. The first J-N itera-
tions ensures the convergence of all the full conditional
distributions. Thus we used a vector of size N to esti-
mate the posterior median and 95% credibility intervals
of the prevalence and the Se and Sp of each test. We fix
N = 2,000 whereas the value of J (< 3,300) depends on
the rate of the convergence. We use starting values for
the prevalence 0.1, for Se and Sp for each of three test
respectively 0.50 and 0.80.
The routine was applied to each group of cats to
evaluate the performance of the three tests in each
group and in the total sample composed by 161 cats. In
details, the statistical analysis at first compared simultan-
eously the three tests in the three groups studied and
gained the true prevalence in each group. In this way it
was possible to understand which test was best accord-
ing to the purpose of diagnosis. Furthermore, this ana-
lysis revealed the critical points related to the estimates
when sample size is small and they are not representa-
tive of the population under investigation. Then, in
order to improve estimates and find the most accurate
test we considered the total sample composed by the
three groups of cats.
Results
Table 1 shows the combination of results obtained by
IFAT, ELISA and WB in each group of cats studied. The
results of the performed simulation of Se, Sp and preva-
lence in the three groups is shown in Table 2.
In cats from non-endemic area, Se of the tests was not
high with best value (41%) offered by WB but with a
high statistical variability (low precision) as represented
by 95% credible intervals (CI) (CI: 2–96%). Obviously,
the high uncertainty is determined by 95% of negative
results obtained by diagnostic tests in this group and by
sample size. Conversely, Sp of tests is high and with high
precision and IFAT offered the best value (99%) as well
as high precision (CI: 94–100%). The true prevalence
calculated simultaneously by the three tests in the non-
endemic area group was 2%.
More false positive and false negative results emerged
in the group of cats from the endemic area. In fact the
best Se (64%) and Sp (98%) respectively, given by WB
and ELISA were both obtained with a low precision.
Precision was low (CI: 1–96%) also for the prevalence
sample (10%).
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In the group of cats affected by leishmaniosis, ELISA
and WB had the same estimate of Se (94%) but ELISA
(CI: 13–100%) had a smaller uncertainty than WB
(CI: 9–100%). As expected, in the group of sick indi-
viduals, Sp values were low and had a low precision
with all tests. However, the best Sp (21%; CI: 1–95%) was
obtained by IFAT. The prevalence sample in this group
was 89% but with a low precision (CI: 1–100%).
One hundred and thirty-five serum sample units out
of 161 (83.8%) produced results in agreement. Table 3
shows the test results for the number of cats which have
one of the 8 different test patterns.
The results of simulation of Se and Sp of IFAT, ELISA
and WB and sample prevalence in the overall 161 sam-
ples are shown in Table 4. As the sample size is larger,
test accuracy was higher and provided a greater preci-
sion. Western blot was the most accurate test: Se = 97%
(CI: 86–100%); Sp = 99% (CI: 96–100%). Sensitivity of
IFAT (75%) was higher and with a higher precision (CI:
61–87%) compared to that of ELISA (70%; CI: 56–83%).
Conversely ELISA Sp (98%) and precision (CI: 94–100%)
slightly exceeded that of IFAT (97%; CI: 93–100%).
Discussion
This is the first study that assesses the diagnostic per-
formance of IFAT, ELISA and WB for the detection of
anti-L. infantum antibodies in sera of cats from non-
endemic and endemic areas (included cats with con-
firmed clinical leishmaniosis) using a Bayesian approach
in the absence of a gold standard. Parasite specific anti-
body detection is a fundamental diagnostic tool for con-
firming a clinical suspicion of leishmaniosis in dogs [6]
but the possibility of discrepancy between different sero-
logical techniques is well known in both dogs and cats
[4, 9, 11, 13, 26]. Serological methods are however less
useful for assessing the infection seroprevalence of dogs
living in endemic areas as subclinical infections are usu-
ally associated with negative or border-line results [6]. In
this study, cats with clinical leishmanosis were 100%
positive with WB or ELISA and 95% with IFAT, support-
ing that antibody detection can be used for confirming
feline leishmaniosis in clinical practice as for canine
leishmaniosis. However, some caution is needed before
excluding leishmaniosis in IFAT negative cats. Sick cats
with clinical picture compatible with leishmaniosis but
negative by IFAT should perform other serological tests
or complementary diagnostic tools such as cytology,
histology or PCR [1].
In endemic areas for Trypanosoma spp. or other
Leishmania spp. cross reactions with L. infantum must
be taken into account for interpretation of serological
Table 1 Combination of results of the three serological tests
detected in each group of cats







IFAT ELISA WB Number of
observations
– – – 61 53 0
– – + 2 9 0
– + – 1 0 0
– + + 0 1 1
+ – – 0 9 0
+ – + 0 3 0
+ + – 0 0 0
+ + + 0 1 20
+, positive test result; −, negative test result
Table 2 Output parameters of the accuracy of tests for each
group of cats studied
IFAT ELISA WB
Median CI Median CI Median CI
Non-endemic area: sample prevalence 0.02% (CI: 0.00–0.16)
Sensitivity 0.33 0.01–0.96 0.38 0.02–0.97 0.41 0.02–0.96
Specificity 0.99 0.94–1.00 0.98 0.92–1.00 0.96 0.90–0.99
Endemic area: sample prevalence 0.10% (CI: 0.01–0.96)
Sensitivity 0.43 0.07–0.93 0.26 0.00–0.94 0.64 0.07–0.99
Specificity 0.84 0.18–0.95 0.98 0.30–1.00 0.84 0.06–0.96
Affected by leishmaniosis: sample prevalence 0.89% (CI: 0.01–1.00)
Sensitivity 0.89 0.08–0.99 0.94 0.13–1.00 0.94 0.09–1.00
Specificity 0.21 0.01–0.95 0.18 0.00–0.93 0.16 0.00–0.94
Abbreviation: CI 0.95 credible interval
Table 3 Results of three serological tests applied to all 161 cats
IFAT ELISA WB No. of observations
– – – 114
– – + 11
– + – 1
– + + 2
+ – – 9
+ – + 3
+ + - 0
+ + + 21
+, positive test result; −, negative test result
Table 4 Output parameters of the accuracy of the tests with all
cats studied. Sample prevalence 0.27; CI = 0.20–0.34
IFAT ELISA WB
Median CI Median CI Median CI
Sensitivity 0.75 0.61–0.87 0.70 0.56–0.83 0.97 0.86–1.00
Specificity 0.97 0.93–0.99 0.98 0.94–1.00 0.99 0.96–1.00
Abbreviation: CI 0.95 credible interval
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tests but this is not the case of the geographical area
of investigation of this study [27–29].
The percentage of antibody positive samples to at least
one technique in the group of 76 cats living in South Italy
reached 30% confirming that feline Leishmania infection
is frequent in endemic areas (2). This feline group is rep-
resentative of an adult feline population admitted for het-
erogeneous reasons to clinical practice in endemic area.
These cats are potentially exposed to the parasite and can
stand in one of the following conditions: not come into
contact with Leishmania, come into contact but not be-
come infected, otherwise they are infected. Moreover, in-
fected individuals can stand at the time of sampling in a
different point of the wide spectrum of clinical situations
going from a subclinical infection to overt disease. ELISA
testing appears to have a low Se for detecting antibodies
compared to WB and IFAT in subclinical infections. This
finding is in contrast with other studies and is of clinical
relevance when there is a need of testing cats in endemic
areas because they are blood donors, before their export-
ation to a non-endemic area or because an immune-
suppressive therapy has to be given [1, 30]. The very strict
calculation that we used (mean value ± 4 SD of sera from
non-endemic area) for ELISA cut-off setting obviously
contributed to this result.
Despite the large number of published serological inves-
tigations, very few studies validated serological techniques
testing for anti-Leishmania antibodies a consistent num-
ber of serum samples obtained from feline patients of
non-endemic area [5, 11, 31, 32]. It is important to
have as much extensive as possible data by testing fe-
line populations of non-endemic regions in order to
exclude the possibility of cross-reactions with other
microbial agents or even with endogenous feline pro-
teins. The current state of the art clearly rule out
cross-reactivity with Toxoplasma gondii only, there-
fore we cannot exclude cross-reactions for some posi-
tive results we obtained [10, 14, 15, 32, 33]. It is
important to remark that the travel and clinical his-
tory were unknown in all cats studied from non-
endemic area and this can be considered a limitation
of this study. However, the overall good discrimin-
ation that we obtained between the three different
categories of cats confirms that we set appropriate
methodologies for IFAT, ELISA and WB techniques.
In particular, we confirmed that 80 is appropriate
IFAT cut-off and the 18 kDa band is marker for posi-
tive WB when testing feline sera likewise it occurs in
dogs and humans [5, 21–23].
Various problems may arise when comparing diagnos-
tic performance of different tests given the absence of a
gold standard diagnostic test for Leishmania infection.
One problem concerns the influence of spectrum (stage
of the disease) and selection (inclusion criteria) bias. For
example, it is more difficult to suspect a disease at an
early stage and the criteria for inclusion of patients to
be tested in a study will be crucial. Ideally, each unit in
the sample should be randomly selected so that the
sample is representative of the target population. This is
difficult to do in field studies and this type of error
yields to misleading statistics. Therefore, it is important
to be aware of the influence of spectrum and selection
bias on the accuracy of diagnostic tests for Leishmania
infection, but this must be kept in perspective. This
means that to carefully assess the Se and Sp of diagnos-
tic tests, samples of cats with confirmed leishmaniosis
as well as of animals from endemic and non-endemic
areas should be selected. Other important factors influ-
encing the diagnostic performance of tests include tech-
nical variations. In this study, cut-off values used for
IFAT and ELISA and the criteria for interpretation of
positive immunoblots in feline sera were confirmed to
be appropriate for discriminating samples from endemic
and non-endemic areas and, among those from endemic
area, between cats with confirmed leishmaniosis and
cats with other clinical problems. The aim of this study
was to evaluate the diagnostic performance of tests fre-
quently used for the detection of anti-Leishmania anti-
bodies in feline sera in the absence of a gold standard.
For the first time, this analytical problem was solved by
writing a routine with MATLAB software in the Bayes-
ian framework. This approach has the main advantage
of drawing inference from diagnostic tests in the ab-
sence of a gold standard. The non-informative beta
prior for parameter provided a minimal effect on the
final inference of three diagnostic tests and we obtained
the maximum of information from the experimental
data. One weak point of this study is, however, given by
the sample size of cats with confirmed leishmaniosis
compared to those non-infected that we could test, as
this can be one possible source for uncertainty of Se of
ELISA (27%) and IFAT (26%) compared to that of WB
(14%). The analysis of a more extensive and better bal-
anced specimen of feline serum samples can confirm or
reject this hypothesis.
Conclusion
The diagnostic performance of serological tests fre-
quently used for the detection of anti-Leishmania anti-
bodies in cats was evaluated in the absence of a gold
standard in the Bayesian framework. The overall per-
formance of WB, IFAT and ELISA was good, but WB
targeting for positivity the 18 kDa band offered the best
diagnostic performance for the detection of antibodies
against L. infantum. Overall, IFAT (cut-off 80) was more
sensitive than ELISA to detect subclinical or early infec-
tions while ELISA was better for diagnosing clinical
leishmaniosis when compared with IFAT. As there is no
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perfect diagnostic test, the best choice for each specific
purpose of diagnosis (infection versus disease) theoretic-
ally is offered by WB because of the highest Se and Sp,
however the analysis of more samples is necessary for
confirming our results.
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